Switzerland Pharmaceuticals and Healthcare Report Q2 2014

Business Monitor International
March 19, 2014
99 Pages - SKU: BMI5218010
Countries covered: Switzerland

Switzerland Pharmaceuticals and Healthcare Report Q2 2014

BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increasedpharmaceutical and healthcare spending. The pensionable population proportion is high and growing, andthis will translate into greater demand for drugs. Furthermore, the country's highly developed infrastructuremeans that access to healthcare is easy, further supporting the consumption of medicines.

Headline Expenditure Projections

Pharmaceuticals: CHF7.19bn (US$7.76bn) in 2013 to CHF7.33bn (US$6.84bn) in 2014; +1.84% inlocal currency terms.

Healthcare: CHF66.37bn (US$71.62bn) in 2013 to CHF67.81bn (US$63.26bn) in 2014; +2.2% growthin local currency terms.Risk/Reward Ratings: In BMI's Q214 Risk/Reward Ratings (RRRs) for Western Europe, Switzerlandstood in third position in the Western Europe matrix. Switzerland's score for the quarter stands at 71.7, wellabove the regional average of 67.4.



More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Uzbekistan Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Uzbekistan Q4 2014BMI View: We expect Uzbekistan's healthcare spending to continue outpacing the country's economicgrowth, creating opportunities for most health ...
Pharmaceuticals and Healthcare Report - United Arab Emirates Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - United Arab Emirates Q4 2014BMI View: The UAE continues to appeal to businesses thanks to its growing economy, which willincreasingly ...
Pharmaceuticals and Healthcare Report - South Africa Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - South Africa Q4 2014BMI View: South Africa's tepid economic growth, depreciating currency and current account deficit willlimit the market potential ...
Pharmaceuticals and Healthcare Report - Serbia Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Serbia Q4 2014BMI View: In July, Serbia's National Health Insurance Fund (RFZO) cut medicine prices by around 50%through a new ...
See all reports like this >>

More Switzerland Prescription Drugs reports

The Pharmaceutical Market: Switzerland by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: Switzerland (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
Pharmaceuticals - Switzerland by Global Research & Data Services
This market analysis gives an overview of the actual situation, trends and future outlook of the pharmaceutical market in Switzerland. The market analysis provides essential ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!